Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

Maryland · 2026 Regular Session · Bill

HB 1045: Prescription Drug Monitoring Program - Data Disclosure to Federal Law Enforcement - Limitation

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

HB 1045 is a bill introduced in the Maryland House on February 9, 2026. According to its official title, it concerns: Prescription Drug Monitoring Program - Data Disclosure to Federal Law Enforcement - Limitation. Primary sponsor: Bonnie Cullison (Democratic). Most recent recorded action (March 3, 2026): Withdrawn by Sponsor.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Sponsors

Sponsors by party (alphabetical): Democratic 1

NameRolePartyChamberDistrict
Bonnie CullisonPrimary sponsorDemocraticHouse19

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. Withdrawn by Sponsor
  2. Hearing canceled
  3. Hearing 2/26 at 1:00 p.m.
  4. First Reading Health

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source